@article{c66211732cf9436bb99a3c675ab197d8,
title = "Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategies",
abstract = "In response to viral infection, cells mount a potent inflammatory response that relies on ISG15 and ubiquitin posttranslational modifications. Many viruses use deubiquitinases and deISGylases that reverse these modifications and antagonize host signaling processes. We here reveal that the leader protease, Lbpro, from foot-and-mouth disease virus (FMDV) targets ISG15 and to a lesser extent, ubiquitin in an unprecedented manner. Unlike canonical deISGylases that hydrolyze the isopeptide linkage after the C-terminal GlyGly motif, Lbpro cleaves the peptide bond preceding the GlyGly motif. Consequently, the GlyGly dipeptide remains attached to the substrate Lys, and cleaved ISG15 is rendered incompetent for reconjugation. A crystal structure of Lbpro bound to an engineered ISG15 suicide probe revealed the molecular basis for ISG15 proteolysis. Importantly, anti-GlyGly antibodies, developed for ubiquitin proteomics, are able to detect Lbpro cleavage products during viral infection. This opens avenues for infection detection of FMDV based on an immutable, host-derived epitope.",
keywords = "FMDV, ISG15, Structure, Ubiquitin, Viral signaling",
author = "Swatek, {Kirby N.} and Martina Aumayr and Pruneda, {Jonathan N.} and Visser, {Linda J.} and Stephen Berryman and Kueck, {Anja F.} and Geurink, {Paul P.} and Huib Ovaa and {van Kuppeveld}, {Frank J.M.} and Tuthill, {Tobias J.} and Tim Skern and David Komander",
note = "Funding Information: ACKNOWLEDGMENTS. We thank Paul R. Elliott and the beamline scientists at Diamond I-04. Access to Diamond Light Source was supported in part by European Union Seventh Framework Program Infrastructure Grant BIOSTRUCT-X (Contract 283570). This work was supported by The Netherlands Organization for Scientific Research Graduate Program Grant NWO-022.004.018 (to L.J.V.), VICI Grants NWO-724.013.002 (to H.O.) and NWO-918.12.628 (to F.J.M.v.K.) from the Netherlands Organization for Scientific Research, the Biotechnology and Biological Sciences Research Council (Pirbright Institute and T.J.T.), Grants P 24038 (to T.S.) and P 28183 (to T.S.) from the Austrian Science Fund, Medical Research Council Grant U105192732 (to D.K.), European Research Council Grants 309756 (to D.K.) and 724804 (to D.K.), and the Lister Institute for Preventive Medicine (D.K.). Publisher Copyright: {\textcopyright} 2018 National Academy of Sciences. All Rights Reserved.",
year = "2018",
month = mar,
day = "6",
doi = "10.1073/pnas.1710617115",
language = "English (US)",
volume = "115",
pages = "2371--2376",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "10",
}